Related Experiment Videos
Phenotype-genotype correlation in CD36 deficiency types I and II
1Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Thrombosis and Haemostasis
|October 6, 2000
Summary
CD36 deficiency, a condition affecting platelets and monocytes, was investigated in Japanese volunteers. Genetic analysis identified specific mutations as the primary causes for CD36 deficiency types I and II.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- CD36 deficiency is characterized by the absence of CD36 protein on platelets (Type II) or on both platelets and monocytes (Type I).
- Understanding the genetic basis of CD36 deficiency is crucial for diagnosing and managing related hematological conditions.
Purpose of the Study:
- To investigate the phenotype-genotype relationship in CD36 deficiency.
- To determine the prevalence of CD36 deficiency types I and II in a Japanese population.
- To identify the genetic mutations responsible for CD36 deficiency.
Main Methods:
- Diagnosis of CD36 deficiency based on CD36 protein expression on platelets and monocytes.
- Genotyping of apparently healthy Japanese volunteers (n=827) to assess deficiency prevalence.
- DNA sequencing to identify mutations in the CD36 gene and flanking regions.
Main Results:
- CD36 deficiency Type I and II were identified in 1.0% and 5.8% of volunteers, respectively.
- A T to C substitution (Pro90Ser) and an A insertion (nt 1159) were the major mutations causing Type I and II deficiencies.
- A dinucleotide deletion at nt539 played a minor role; novel polymorphisms were found in regulatory regions.
Conclusions:
- The study elucidates the primary genetic causes of CD36 deficiency (Types I and II) in the Japanese population.
- Findings challenge the hypothesis of a platelet-specific silent allele near the CD36 gene.
- Identified mutations provide valuable targets for genetic screening and understanding CD36-related disorders.